$1.36 Billion is the total value of Davide Leone & Partners Investment Co Ltd.'s 16 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AABA | New | ALTABA INC | $311,860,000 | – | 4,207,500 | +100.0% | 23.00% | – |
| BABA | New | ALIBABA GROUP HLDG LTDcall | $295,989,000 | – | 1,622,300 | +100.0% | 21.83% | – |
| T | New | AT&T INC | $123,462,000 | – | 3,936,935 | +100.0% | 9.10% | – |
| BMY | New | BRISTOL MYERS SQUIBB COcall | $95,420,000 | – | 2,000,000 | +100.0% | 7.04% | – |
| CELG | New | CELGENE CORP | $95,095,000 | – | 1,008,000 | +100.0% | 7.01% | – |
| BB | New | BLACKBERRY LTD | $85,392,000 | – | 8,463,064 | +100.0% | 6.30% | – |
| INCY | New | INCYTE CORP | $62,783,000 | – | 729,953 | +100.0% | 4.63% | – |
| NXPI | New | NXP SEMICONDUCTORS N V | $54,895,000 | – | 621,053 | +100.0% | 4.05% | – |
| NLSN | New | NIELSEN HLDGS PLC | $43,174,000 | – | 1,824,000 | +100.0% | 3.18% | – |
| NLSN | New | NIELSEN HLDGS PLCput | $43,174,000 | – | 1,824,000 | +100.0% | 3.18% | – |
| New | ILLUMINA INCnote 0.500% 6/1 | $39,976,000 | – | 29,461,000 | +100.0% | 2.95% | – | |
| WP | New | WORLDPAY INCcl a | $30,183,000 | – | 265,931 | +100.0% | 2.23% | – |
| ZAYO | New | ZAYO GROUP HLDGS INC | $29,558,000 | – | 1,040,025 | +100.0% | 2.18% | – |
| ACHC | New | ACADIA HEALTHCARE COMPANY IN | $27,550,000 | – | 939,954 | +100.0% | 2.03% | – |
| New | ILLUMINA INCnote 6/1 | $17,200,000 | – | 14,000,000 | +100.0% | 1.27% | – | |
| BRKA | New | BERKSHIRE HATHAWAY INC DELcl a | $301,000 | – | 1 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL | 19 | Q3 2023 | 7.8% |
| ACADIA HEALTHCARE COMPANY IN | 9 | Q4 2021 | 14.1% |
| BLACKBERRY LTD | 9 | Q4 2021 | 10.1% |
| ILLUMINA INC | 8 | Q4 2020 | 8.8% |
| ENCOMPASS HEALTH CORP | 7 | Q2 2022 | 98.2% |
| INCYTE CORP | 6 | Q1 2021 | 5.0% |
| AMERICAN WELL CORP | 6 | Q4 2021 | 2.7% |
| BIOMARIN PHARMACEUTICAL INC | 5 | Q3 2021 | 9.1% |
| VONTIER CORPORATION | 5 | Q4 2021 | 9.9% |
| QIAGEN NV | 5 | Q1 2021 | 7.7% |
View Davide Leone & Partners Investment Co Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR/A | 2021-11-16 |
View Davide Leone & Partners Investment Co Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.